≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Hyperaldosteronism

DOID EFO Endpoint Browser PheWeb

E4_HYPERALDO

hyperaldosteronism: Overproduction of aldosterone by the adrenal glands, which may lead to hypokalemia and/or hypernatremia. [ NCIT:P378 ]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E26
  • Hospital discharge: ICD-9 — 2551
  • Hospital discharge: ICD-8 — 25500
  • Cause of death: ICD-10 — E26
  • Cause of death: ICD-9 — 2551
  • Cause of death: ICD-8 — 25500

2 out of 7 registries used, show all original rules.

971

4. Check minimum number of events

None

971

5. Include endpoints

None

971

6. Filter based on genotype QC (FinnGen only)

971

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E20-E35
Name in latin
Hyperaldosteronismus

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5523 2949 2543
Only index persons 5035 2705 2330
Unadjusted period prevalence (%)
Whole population 0.08 0.08 0.07
Only index persons 0.09 0.10 0.09
Median age at first event (years)
Whole population 57.31 56.48 58.24
Only index persons 56.72 55.67 57.95

-FinnGen-

Key figures

All Female Male
Number of individuals 971 518 453
Unadjusted period prevalence (%) 0.19 0.18 0.20
Median age at first event (years) 56.90 54.90 59.18

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
859
Matched controls
8588
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E26.0
ICD-10 Finland
Primary hyperaldosteronism
16384.0
323.0
666
*
C03DA01
ATC
spironolactone; oral
72.4
323.0
698
485
E26.9
ICD-10 Finland
Hyperaldosteronism, unspecified
+∞
196.6
181
*
205
Kela drug reimbursment
Chronic hypertension
7.3
155.4
533
1567
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
48.8
150.0
182
47
A12BA01
ATC
potassium chloride; oral
22.2
148.7
224
134
BC4WT
NOMESCO Finland
Selective blood sample from adrenal gland with radiological guidance
+∞
142.8
133
*
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
300.2
128.9
128
5
E87.6
ICD-10 Finland
Hypokalaemia
23.6
125.4
184
98
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
+∞
124.0
116
*
I10
ICD-10 Finland
Essential (primary) hypertension
6.8
115.9
732
3941
C08CA01
ATC
amlodipine; oral
5.2
110.0
551
2206
BC1AD
NOMESCO Finland
CT of adrenal glands
66.8
105.4
121
21
E260, I152
ICD-10 Finland
NA
+∞
88.0
83
*
C02AC05
ATC
moxonidine; oral
9.7
71.3
154
190
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
46.1
58.9
72
17
C08CA13
ATC
lercanidipine; oral
4.4
54.9
233
673
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
4.1
53.9
253
802
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
58.6
47.1
55
10
C08CA02
ATC
felodipine; oral
4.9
46.7
169
409
C07AB07
ATC
bisoprolol; oral
2.8
45.1
523
3069
2551A
ICD-9 Finland
Disorders of adrenal glands, Hyperaldosteronism
+∞
42.0
40
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
23.4
41.1
59
27
E26.8
ICD-10 Finland
Other hyperaldosteronism
+∞
36.7
35
*
E26.1
ICD-10 Finland
Secondary hyperaldosteronism
+∞
35.7
34
*
C09AA02
ATC
enalapril; systemic
3.0
35.2
249
1029
C07AG02
ATC
carvedilol; oral
5.3
35.1
113
237
C08CA05
ATC
nifedipine; systemic
5.0
34.0
117
264
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
7.9
30.3
71
97
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
30.1
267
1253
E26
ICD-10 Finland
Hyperaldosteronism
+∞
29.3
28
*
C07AB02
ATC
metoprolol; systemic
2.7
28.9
245
1117
C09CA01
ATC
losartan; oral
2.5
28.2
271
1320
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.5
27.9
279
1387
A10BA02
ATC
metformin; oral
2.4
26.9
305
1615
103
Kela drug reimbursment
Diabetes, insulin-treated
2.4
26.3
291
1517
C09BA02
ATC
enalapril and diuretics; systemic
3.7
25.4
121
368
BCA30
NOMESCO Finland
Unilateral adrenalectomy
72.1
24.9
28
*
C09CA06
ATC
candesartan; oral
2.4
24.5
246
1212
25500
ICD-8 Finland
Diseases of adrenal glands, Aldosteronismus. Syndroma Conn
+∞
24.1
23
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
246.5
23.8
24
*
C03DB01
ATC
amiloride; oral
123.3
22.7
24
*
C08DB01
ATC
diltiazem; oral
4.2
21.8
87
226
4019X
ICD-9 Finland
Essential hypertension, Unspecified
6.4
21.7
58
96
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.5
20.2
186
866
T90
ICPC
Diabetes non-insulin dependent
2.2
20.0
245
1310
C09DA01
ATC
losartan and diuretics; oral
2.8
19.1
132
519
XF602
NOMESCO Finland
Bloodpressure monitoring
13.1
19.0
33
26
C08CA03
ATC
isradipine; systemic
14.6
18.7
31
22
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.8
18.1
79
222
C03AA03
ATC
hydrochlorothiazide; oral
2.9
17.8
118
451
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
17.8
17
*
E21.0
ICD-10 Finland
Primary hyperparathyroidism
32.2
17.1
22
7
K85
ICPC
Elevated blood pressure
2.4
16.5
163
778
C02EA02
ATC
NA
4.2
16.2
63
160
C07AB08
ATC
celiprolol; oral
5.4
16.0
48
93
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
4.1
15.9
63
163
40199
ICD-8 Finland
Essential benign hypertension
7.2
15.8
38
55
C09CA03
ATC
valsartan; oral
2.7
15.7
114
460
I15.8
ICD-10 Finland
Other secondary hypertension
86.7
15.6
17
*
C08CA10
ATC
nilvadipine; oral
6.5
15.5
40
64
C03BA11
ATC
indapamide; oral
5.2
15.4
48
97
C02LM02
ATC
NA
8.5
15.4
33
40
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
15.2
182
948
BC1BD
NOMESCO Finland
Extensive CT of adrenal glands
57.7
14.8
17
*
C02DE10
ATC
NA
10.7
14.8
28
27
SPAT1262
SPAT
Handing over of treatment supplies
2.1
14.6
190
1024
C09DA06
ATC
candesartan and diuretics; oral
2.8
14.3
94
355
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.6
14.2
66
196
2533
FHL
Unilateral removal of additional egg
+∞
13.6
13
*
C03CA01
ATC
furosemide; systemic
1.9
13.5
250
1535
N18.8
ICD-10 Finland
Other chronic renal failure
5.1
13.1
41
84
C09CA07
ATC
telmisartan; oral
2.8
13.0
84
315
G47.3
ICD-10 Finland
Sleep apnoea
1.9
12.8
212
1247
C07FB02
ATC
metoprolol and felodipine; systemic
4.4
12.8
46
109
I152, E260
ICD-10 Finland
NA
+∞
12.5
12
*
207
Kela drug reimbursment
Chronic arrhythmias
2.2
12.5
143
724
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.4
12.1
58
177
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.9
11.7
48
129
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.9
11.4
31
54
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.9
11.4
198
1182
E66.00
ICD-10 Finland
Metabolic syndrome
3.2
11.4
59
192
C02CA01
ATC
prazosin; oral
7.2
11.1
26
37
C09DB01
ATC
valsartan and amlodipine; oral
3.8
10.8
45
123
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
10.7
379
2795
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
10.6
248
1622
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
32.9
10.3
13
*
A10BH01
ATC
sitagliptin; oral
2.2
10.3
104
496
R06.0
ICD-10 Finland
Dyspnoea
1.8
10.2
214
1353
C07AB03
ATC
atenolol; systemic
2.8
10.1
67
256
B01AA03
ATC
warfarin; systemic
1.9
9.9
173
1027
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
9.9
151
858
C02DE02
ATC
NA
5.8
9.9
27
48
A11CC03
ATC
alfacalcidol; systemic
5.2
9.8
29
57
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
9.6
182
1113
H02AB09
ATC
hydrocortisone; systemic
6.5
9.6
24
38
C02EA03
ATC
NA
7.3
9.5
22
31
TFP20
NOMESCO Finland
Cardiodefibrillation
2.4
9.4
79
345
PC5CG
NOMESCO Finland
Extensive MRI examination of kidney vasculature with high intensity magnet
30.4
9.4
12
*
A10BH05
ATC
linagliptin; oral
2.9
9.3
56
203
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
9.6
9.3
18
19
C08DA01
ATC
verapamil; systemic
3.2
9.2
47
152
C07BB07
ATC
bisoprolol and thiazides; systemic
3.1
9.0
49
167
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
6.0
8.8
23
39
C09DA07
ATC
telmisartan and diuretics; oral
2.9
8.7
51
182
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
8.5
147
868
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.9
8.4
49
174
H05BX01
ATC
cinacalcet; oral
+∞
8.3
8
*
C07AB04
ATC
acebutolol; systemic
5.6
8.3
23
42
C07AB05
ATC
betaxolol; oral
3.9
8.3
33
88
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.2
729
6565
C10AA01
ATC
simvastatin; oral
1.5
8.2
371
2849
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
7.9
259
1836
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
7.8
229
1575
XF404
NOMESCO Finland
Ambulatory ECG
2.1
7.8
92
474
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
7.8
91
463
A12AA04
ATC
calcium carbonate; oral
6.4
7.7
19
30
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
7.7
103
557
R4110
NOMESCO Finland
Physiotherapy
1.6
7.5
221
1523
J01MA02
ATC
ciprofloxacin; systemic
1.5
7.4
313
2350
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
7.3
86
438
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
8.5
7.3
15
18
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
7.3
7
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
7.3
7
*
E24.8
ICD-10 Finland
Other Cushing syndrome
+∞
7.3
7
*
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
5.2
7.3
21
41
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.6
7.3
50
197
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
7.2
77
378
C09CA08
ATC
olmesartan medoxomil; oral
4.7
7.2
23
50
A10BJ06
ATC
semaglutide; parenteral
3.1
7.2
37
122
C09AA03
ATC
lisinopril; oral
2.7
7.2
46
174
I15
ICD-10 Finland
Secondary hypertension
30.3
7.2
9
*
321
Kela drug reimbursment
Paricalcitol and cinacalcet
30.3
7.2
9
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
7.0
194
1313
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
10.1
7.0
13
13
C07AB12
ATC
nebivolol; oral
3.2
7.0
34
108
A10BK03
ATC
empagliflozin; oral
2.1
6.9
73
359
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
6.9
174
1150
R04.0
ICD-10 Finland
Epistaxis
2.2
6.9
65
303
WX110
NOMESCO Finland
Local anesthesy
1.5
6.9
547
4666
C09DA03
ATC
valsartan and diuretics; oral
2.5
6.8
52
219
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
40.4
6.8
8
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.8
6.8
124
747
A10BB12
ATC
glimepiride; oral
2.2
6.7
64
298
B01AF02
ATC
apixaban; oral
2.0
6.7
86
459
C09DX01
ATC
valsartan, amlodipine and hydrochlorothiazide; oral
3.9
6.6
25
65
C02DE04
ATC
NA
3.4
6.6
30
91
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
6.5
122
738
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.8
6.5
108
632
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
6.4
274
2048
M04AA01
ATC
allopurinol; systemic
1.8
6.4
109
638
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
6.4
218
1548
N02AX02
ATC
tramadol; systemic, rectal
1.5
6.4
344
2700
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.6
6.3
17
31
N05BA04
ATC
oxazepam; oral
1.6
6.3
194
1345
D350, E260
ICD-10 Finland
NA
+∞
6.3
6
*
E260, D350
ICD-10 Finland
NA
+∞
6.3
6
*
A10AE04
ATC
insulin glargine; parenteral
2.0
6.2
82
437
C02EA06
ATC
NA
26.9
6.2
8
*
J01MA06
ATC
norfloxacin; oral
1.8
6.2
109
644
R60.0
ICD-10 Finland
Localized oedema
1.9
6.2
95
536
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.8
6.2
36
130
C02DE12
ATC
NA
7.7
6.1
13
17
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.7
6.1
13
17
R03BA02
ATC
budesonide; inhalant
1.7
6.1
134
850
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
6.1
100
581
C09BA03
ATC
lisinopril and diuretics; oral
3.4
6.1
27
81
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.8
6.1
36
132
K86
ICPC
Hypertension uncomplicated
1.8
6.0
104
611
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.2
6.0
21
51
E66.9
ICD-10 Finland
Obesity, unspecified
3.1
6.0
31
104

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
288
87
46.64
307.65
3.0
1.2
pmol/l
537.2
304.2
4.04
248
73
(3011985) Renin [Units/volume] in Plasma
308
89
50.22
307.65
2.7
1.2
mu/l
72.1
53.4
0.23
273
82
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
169
90
22.52
220.06
1.3
1.2
nmol/l
0.6
0.6
0.46
159
83
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
157
86
21.58
201.47
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
145
77
21.96
188.37
1.3
1.2
nmol/l
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
81
24
36.73
128.72
1.7
1.1
pmol/l
731.7
368.1
2.46
59
16
(3036481) Cortisol [Moles/volume] in Serum or Plasma
275
691
5.16
105.66
2.4
2.0
nmol/l
324.9
373.8
2.97
261
637
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
72
30
25.84
102.14
1.6
1.4
nmol/l
3.7
1.1
1.08
63
25
(3012095) Magnesium [Moles/volume] in Serum or Plasma
369
1325
3.88
86.21
3.0
3.4
mmol/l
0.8
0.8
0.36
347
1251
(3036603) Volume of Urine
67
52
13.77
70.58
1.7
1.5
ml
2384.1
1819.8
—
20
9
(3035637) Corticotropin [Mass/volume] in Plasma
76
74
11.06
69.34
1.7
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
675
4065
3.17
60.45
9.5
6.7
mmol/l
1.2
1.2
0.46
570
3455
(3018418) pH of Serum or Plasma
481
2410
2.97
60.37
6.0
3.9
ph
7.4
7.4
0.02
106
448
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
623
3704
2.90
54.89
9.0
6.0
mmol/l
1.2
1.2
0.47
591
3361
(3020682) Albumin/Creatinine [Ratio] in Urine
490
2637
2.73
51.32
4.9
3.9
mg/mmol
15.0
8.5
1.82
324
1683
(3012516) Albumin [Mass/volume] in Urine
464
2494
2.65
47.78
3.8
3.2
mg/l
81.0
303.3
2.20
315
1604
(3009508) Creatinine [Moles/volume] in Urine
475
2609
2.61
46.40
3.8
3.1
mmol/l
7.2
7.7
1.54
408
2183
(3003458) Phosphate [Moles/volume] in Serum or Plasma
257
1047
2.98
44.93
8.8
5.7
mmol/l
1.1
1.0
0.17
242
969
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
173
557
3.56
44.77
5.8
3.4
ng/l
109.9
83.1
2.94
156
491
(3032080) INR in Blood by Coagulation assay
546
3428
2.35
36.94
11.2
9.5
inr
1.2
1.3
0.87
242
967
(3014576) Chloride [Moles/volume] in Serum or Plasma
242
1071
2.68
35.23
6.8
7.5
mmol/l
104.2
104.3
0.10
242
1045
(3002582) Erythrocytes [#/volume] in Urine
426
2493
2.26
32.95
3.7
3.2
e6/l
22.2
93.4
1.86
336
1930
(3030467) Casts [#/volume] in Urine by Automated count
401
2300
2.27
32.44
3.7
3.1
e6/l
0.5
0.5
0.03
305
1745
(3024561) Albumin [Mass/volume] in Serum or Plasma
539
3522
2.19
31.10
5.7
4.8
g/l
36.1
35.4
2.84
500
3289
(36304419) Bacteria [Presence] in Urine
385
2223
2.21
30.13
3.7
3.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
466
2907
2.16
29.90
4.3
3.7
e6/l
131.6
97.5
0.15
352
2082
(3021589) Normoblasts [#/volume] in Blood
540
3576
2.15
29.54
11.9
9.8
e9/l
0.0
0.0
0.71
463
2929
(3026782) Osmolality of Urine
300
1608
2.25
27.78
3.4
2.8
mosm/kgh2o
529.5
556.1
1.45
258
1370
(3000991) Gas panel - Venous blood
168
704
2.68
26.68
10.1
9.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
737
5629
2.28
26.57
5.4
4.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
311
1736
2.16
25.71
3.0
2.5
e6/l
3.9
5.6
1.89
275
1533
(3020779) Urea [Moles/volume] in Serum or Plasma
169
726
2.61
25.46
10.9
7.2
mmol/l
11.3
9.8
1.50
160
694
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
112
391
3.11
24.84
5.6
4.0
mmol/l
24.0
24.2
0.30
101
353
(3013826) Glucose [Moles/volume] in Serum or Plasma
654
4856
2.06
24.05
6.3
5.0
mmol/l
7.1
6.7
3.29
624
4573
(3033658) Prothrombin time (PT) actual/Normal
347
2071
2.05
23.65
4.1
4.0
%
87.8
89.6
0.55
342
2023
(3012544) pH of Venous blood
174
789
2.47
23.26
5.2
3.7
—
7.4
—
0
5
(3002032) Base excess in Venous blood by calculation
170
771
2.46
22.68
5.2
3.7
mmol/l
1.8
2.1
0.35
143
610
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
480
3256
1.94
22.26
2.9
2.1
nmol/l
76.0
77.1
0.38
440
2881
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
74
214
3.66
22.09
3.0
3.7
mg/l
1.7
1.6
0.18
65
196
(3021447) Carbon dioxide [Partial pressure] in Venous blood
169
780
2.41
21.64
5.3
3.6
kpa
5.9
5.8
0.17
164
755
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
784
6340
2.23
21.53
8.7
7.6
u/l
76.1
78.5
1.08
761
5947
(3026493) Urate [Moles/volume] in Serum or Plasma
349
2169
1.95
20.61
3.2
2.7
umol/l
4660.6
7412.4
0.50
295
1875
(3044889) 12 lead EKG panel
740
5901
2.07
20.36
5.0
3.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
413
2729
1.89
20.14
5.9
5.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
527
3783
1.86
19.61
6.5
6.0
%
2.9
2.8
0.11
497
3524
(3019069) Monocytes/100 leukocytes in Blood
528
3807
1.85
19.22
6.7
6.3
%
8.6
8.7
0.47
500
3562
(3006315) Basophils [#/volume] in Blood
551
4034
1.85
19.01
6.3
5.8
e9/l
0.0
0.0
0.77
477
3483
(3022096) Basophils/100 leukocytes in Blood
513
3677
1.84
18.93
6.6
6.0
%
0.7
0.7
0.05
482
3426
(3001604) Monocytes [#/volume] in Blood
549
4020
1.84
18.87
6.3
5.8
e9/l
0.6
0.6
1.90
472
3464
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
884
7658
2.72
18.63
8.4
5.8
mmol/mol
41.7
40.0
5.22
834
7103
(3018010) Neutrophils/100 leukocytes in Blood
527
3827
1.82
18.45
6.5
5.9
%
59.4
57.5
3.30
498
3579
(1616796) Gas panel - Central venous blood
62
180
3.61
18.39
4.7
3.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
532
3883
1.82
18.23
6.6
6.1
%
26.1
27.5
2.44
499
3612
(3013115) Eosinophils [#/volume] in Blood
563
4181
1.82
18.21
6.4
6.1
e9/l
0.2
0.2
0.58
492
3676
(3019198) Lymphocytes [#/volume] in Blood
555
4115
1.81
17.93
6.4
5.9
e9/l
1.8
1.9
0.89
480
3618
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
201
1080
2.09
17.51
4.5
2.5
%
23.4
22.9
0.20
178
926
(3015377) Calcium [Moles/volume] in Serum or Plasma
407
2768
1.81
17.40
3.5
3.4
mmol/l
2.4
2.3
0.30
361
2411
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
752
6169
1.97
17.17
4.8
3.8
pmol/l
15.0
14.8
1.39
690
5591
(3004789) Transferrin [Mass/volume] in Serum or Plasma
210
1159
2.04
16.96
4.3
2.4
g/l
2.3
2.3
0.06
197
1075
(3022948) Iron [Moles/volume] in Serum or Plasma
222
1255
2.00
16.74
4.2
2.5
umol/l
13.1
13.0
0.11
210
1161
(3002385) Erythrocyte distribution width [Ratio]
797
6709
2.05
16.37
25.5
18.0
%
13.7
13.7
0.05
787
6577
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
570
4331
1.77
16.25
5.6
6.4
umol/l
11.9
11.5
0.24
540
4125
(3012501) Base excess in Blood by calculation
57
170
3.50
16.24
6.3
4.1
mmol/l
3.2
2.6
0.68
43
117
(3021601) Nitrite [Presence] in Urine by Test strip
533
3978
1.75
16.13
5.8
4.9
estimate
0.0
0.0
0.50
135
724
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
47
124
3.93
15.99
5.9
3.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
605
4695
1.77
15.83
8.3
9.3
e9/l
4.4
4.1
2.86
527
4113
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
365
2461
1.77
15.65
3.5
3.0
ng/l
1778.7
1195.0
1.28
311
2120
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
854
7416
2.26
15.57
5.9
4.6
mu/l
1.9
1.9
0.18
797
6760
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
136
656
2.25
15.46
6.2
3.8
mmol/l
1.2
1.2
0.44
126
570
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
260
1592
1.86
15.27
4.3
4.0
ng/l
647.0
341.9
0.25
215
1271
(3035350) Ketones [Presence] in Urine by Test strip
528
3976
1.72
15.07
4.5
3.6
estimate
0.0
0.0
0.00
135
721
(3009261) Glucose [Presence] in Urine by Test strip
533
4029
1.72
14.95
4.5
3.6
estimate
0.0
0.0
0.50
126
701
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
226
1334
1.90
14.82
3.1
3.0
e6/l
1.9
2.2
0.25
115
742
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
239
1437
1.88
14.80
3.0
2.7
e6/l
0.8
1.1
1.62
128
841
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
874
7720
2.32
14.31
24.0
13.4
ml/min/173m2
73.5
79.8
12.03
781
6385
(3024928) Oxygen saturation in Venous blood
58
191
3.17
14.13
2.6
3.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
726
6056
1.79
13.59
4.8
4.0
mm/h
13.7
12.4
1.21
685
5596
(3002256) Pathology report gross observation
182
1029
1.95
13.46
1.4
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
927
8455
3.13
13.46
30.9
16.9
mmol/l
139.5
139.7
1.30
916
8229
(40768804) Tissue Pathology biopsy report
448
3294
1.67
13.43
2.3
2.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
130
651
2.15
13.41
4.3
2.9
kpa
5.0
4.5
1.39
124
627
(3017817) Protein [Mass] in Urine collected for unspecified duration
32
72
4.56
13.38
2.2
2.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
378
2675
1.68
13.02
2.9
3.3
u/l
30.9
32.5
0.29
357
2544
(3023103) Potassium [Moles/volume] in Serum or Plasma
927
8477
3.06
12.95
32.3
17.0
mmol/l
3.9
4.0
15.39
916
8245
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
98
445
2.34
12.79
11.1
11.4
mmol/l
24.5
24.6
0.02
92
423
(40758558) Short blood count panel - Blood
301
2013
1.72
12.75
6.1
7.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
66
248
2.78
12.75
2.8
3.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
131
673
2.09
12.62
4.6
3.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
331
2279
1.69
12.55
5.0
4.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
897
8096
2.42
12.49
21.0
14.6
mg/l
21.4
24.6
2.44
765
6457
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
260
2.69
12.17
2.6
2.5
u/ml
0.3
0.4
0.23
36
146
(3022217) INR in Platelet poor plasma by Coagulation assay
183
1080
1.86
11.76
32.8
25.5
inr
1.5
1.3
0.69
18
144
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
325
2263
1.66
11.62
1.7
1.7
mmol/l
1.6
1.4
3.20
277
1902
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
142
777
1.97
11.46
2.7
2.6
u/l
31.5
41.9
1.00
120
669
(3031040) Bacteria [#/volume] in Urine by Automated count
650
5378
1.63
11.25
5.7
4.5
e6/l
579.0
3096.2
—
6
91
(3020630) Protein [Mass/volume] in Serum or Plasma
129
688
2.01
11.18
2.5
3.0
g/l
66.1
66.7
0.40
115
634
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
885
8008
2.19
11.15
6.1
4.7
mmol/l
6.4
6.0
9.94
828
7299
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
427
3205
1.59
11.11
4.6
3.7
ng/l
42.7
50.5
0.22
321
2291
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
91
425
2.26
11.11
3.2
3.2
pmol/l
4.3
4.5
1.81
82
378
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
447
3394
1.59
11.06
2.2
2.0
pmol/l
93.5
95.2
0.32
235
1776
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
159
918
1.88
10.90
2.6
4.3
u/l
234.9
252.1
0.79
143
869
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
101
497
2.15
10.84
4.5
3.7
mmol/l
2.3
1.9
0.37
70
384
(3017446) Testosterone [Moles/volume] in Serum or Plasma
114
589
2.06
10.77
2.5
2.1
nmol/l
11.7
12.8
0.24
98
523
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
105
528
2.11
10.66
4.6
3.7
kpa
5.1
5.2
0.41
97
498
(3027801) Oxygen [Partial pressure] in Arterial blood
165
974
1.84
10.52
8.5
8.1
kpa
12.1
12.1
0.01
159
935
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
165
974
1.84
10.52
8.5
8.1
kpa
5.3
5.1
0.93
159
934
(3044640) Blood type and Crossmatch panel - Blood
362
2639
1.59
10.51
2.4
2.5
—
—
—
0
0
(3009343) pH of Capillary blood
103
519
2.10
10.40
4.6
3.7
ph
7.4
7.4
0.19
23
73
(3041096) Erythrocytes [Presence] in Urine by Automated
304
2141
1.61
10.12
4.2
3.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
15
22
6.91
9.75
1.0
1.1
umol/24h
0.6
0.7
—
7
13
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
232
1543
1.66
9.64
3.4
3.1
mmol/l
2.4
2.5
0.24
201
1358
(3003396) Base excess in Arterial blood by calculation
161
978
1.77
9.28
8.6
8.1
mmol/l
1.3
1.3
0.05
133
764
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
343
2528
1.55
9.21
2.3
2.2
u/l
186.0
234.6
0.63
325
2386
(40767503) Oxygen content in Capillary blood by calculation
46
172
2.76
9.01
3.0
2.6
%
18.3
16.0
2.94
30
96
(3006184) Hemoglobin [Mass/volume] in Capillary blood
46
177
2.68
8.54
1.8
2.4
g/l
138.0
129.4
1.28
35
133
(3000690) Aldosterone [Moles/time] in 24 hour Urine
8
0
+∞
8.34
1.1
0.0
nmol/24h
41.9
—
—
8
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
98
528
1.95
8.22
3.9
3.4
g/l
132.5
127.9
1.11
98
519
(3001122) Ferritin [Mass/volume] in Serum or Plasma
433
3416
1.48
8.15
4.1
2.7
ug/l
153.8
137.2
0.92
402
3150
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
256
1809
1.56
8.12
1.8
1.7
mg/l
0.9
1.2
1.37
193
1390
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
60
269
2.31
8.09
2.4
3.9
mg/l
36.0
43.7
0.28
49
219
(3026008) Bacteria identified in Urine by Culture
326
2433
1.51
8.03
3.6
3.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
480
3882
1.47
7.87
4.2
4.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
59
269
2.27
7.66
2.4
3.9
mg/l
42.5
75.4
0.76
48
218
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
342
2601
1.49
7.60
2.8
2.6
u/l
58.1
57.3
0.13
313
2410
(40761511) CBC panel - Blood by Automated count
905
8450
2.04
7.46
20.4
13.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
47
196
2.47
7.44
1.8
4.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
291
2149
1.51
7.44
5.0
3.9
estimate
0.0
0.0
0.09
125
694
(4035726)
122
730
1.77
7.35
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
807
7301
1.62
7.33
24.1
15.9
%
40.1
39.9
0.30
569
5141
(3021960) Folate [Moles/volume] in Serum or Plasma
275
2014
1.51
7.29
1.7
1.5
nmol/l
18.3
20.8
2.46
249
1702
(3021901) Oxygen saturation in Capillary blood
40
156
2.63
7.27
2.6
2.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
49
213
2.37
7.10
2.7
2.5
ug/min
139.2
73.2
0.53
28
130
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
889
8278
1.88
6.99
6.3
5.0
mmol/l
2.6
2.7
7.89
822
7607
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
389
3071
1.44
6.98
4.9
3.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
289
2.15
6.84
2.4
2.6
g/l
10.4
10.6
0.14
52
251
(3023520) Reticulocytes [#/volume] in Blood
114
689
1.74
6.63
2.3
2.8
e9/l
73.5
71.0
0.35
79
531
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
274
2040
1.48
6.60
2.5
2.1
mg/l
2.9
3.1
0.38
234
1743
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
920
8688
2.12
6.60
13.7
10.6
u/l
33.2
26.3
0.73
899
8367
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
135
860
1.66
6.47
4.9
3.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
845
7794
1.65
6.38
4.9
4.0
mmol/l
1.5
1.3
10.45
773
7113
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
144
939
1.63
6.29
2.8
2.7
umol/l
6.7
8.5
0.58
120
824
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
868
8075
1.71
6.17
5.6
4.5
mmol/l
1.3
1.5
23.35
800
7411
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
35
139
2.57
6.17
2.3
1.6
pmol/l
188.5
216.3
0.90
30
125
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
310
2.03
6.07
2.4
2.5
g/l
3.7
3.8
0.15
42
228
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
90
521
1.80
6.07
1.6
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
42
184
2.34
6.02
1.3
1.6
nmol/l
1.4
0.8
1.14
30
154
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
311
2.03
6.01
2.4
2.5
g/l
7.5
7.5
0.11
43
238
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
311
2.03
6.01
2.4
2.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
70
375
1.93
6.00
1.7
2.0
g/l
1.6
1.6
0.01
60
324
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
196
1387
1.52
5.99
1.9
1.9
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
48
224
2.20
5.94
2.3
2.7
g/l
0.0
0.0
0.00
43
209
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
82
466
1.83
5.87
11.1
11.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
140
923
1.60
5.84
2.3
2.7
%
1.9
1.8
0.93
125
835
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
871
8132
1.69
5.83
5.6
4.5
mmol/l
4.4
4.6
12.67
812
7513
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
92
543
1.77
5.81
12.4
10.3
%
0.7
0.7
0.16
92
538
(3037522) Nuclear Ab [Titer] in Serum
156
1058
1.57
5.77
1.3
1.3
titre
340.7
451.0
0.50
27
229
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
65
345
1.95
5.73
2.2
2.1
u/l
43.0
39.7
0.72
55
306
(3022145) Colonoscopy Study observation
141
937
1.59
5.69
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
613
5367
1.39
5.52
3.4
3.1
u/l
49.9
50.6
0.08
584
4990
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
91
545
1.74
5.48
12.3
10.1
%
1.2
1.3
0.95
91
540
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
226
1674
1.46
5.47
1.2
1.2
u/ml
1.0
1.7
0.82
60
454
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
49
239
2.11
5.45
2.3
2.7
g/l
0.0
0.0
0.00
44
223
(3004588) Protein electrophoresis panel - Serum or Plasma
94
569
1.72
5.45
2.9
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
68
375
1.87
5.37
5.3
3.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
50
248
2.07
5.33
2.4
2.6
g/l
36.4
37.4
0.59
43
217
(3007164) IgA [Mass/volume] in Serum or Plasma
207
1517
1.46
5.28
1.4
1.5
g/l
2.5
2.5
0.25
116
924
(3004541) Aldosterone [Moles/volume] in Urine
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
248
1890
1.42
5.11
4.0
3.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
162
1143
1.50
4.98
2.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
142
976
1.53
4.93
1.6
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
96
601
1.66
4.92
3.4
4.6
%
0.0
0.6
0.57
23
161
(21494890) Protein electrophoresis panel - 24 hour Urine
24
89
2.74
4.87
1.6
2.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
12
28
4.33
4.83
1.2
1.3
%
64.6
59.5
—
7
22
(3021440) Promyelocytes/100 leukocytes in Blood
100
637
1.64
4.80
3.4
4.6
%
0.2
0.1
0.31
26
188
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
42
3.61
4.78
7.3
7.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
20
69
2.94
4.62
1.8
4.2
%
11.5
10.9
0.24
20
69
(3037121) Protein [Mass/volume] in Urine
54
291
1.91
4.60
3.3
3.2
g/l
0.3
0.2
0.35
29
124
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
118
791
1.56
4.58
2.1
2.2
g/l
0.2
0.2
1.16
106
739
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51
270
1.94
4.58
2.3
2.9
g/l
0.3
1.4
2.51
44
241
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
141
988
1.50
4.47
1.7
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
159
1142
1.47
4.46
1.2
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
64
369
1.79
4.42
1.1
1.5
—
16.2
—
0
8
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
16
50
3.24
4.35
1.3
1.1
u/l
90.2
77.9
0.38
11
45
(3007853) Bacteria identified in Skin by Aerobe culture
135
955
1.48
4.08
2.0
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
86
2.59
4.07
1.2
1.2
u/l
50.5
53.0
0.11
12
61
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
49
269
1.87
3.98
1.7
1.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
15
48
3.16
3.94
1.3
1.1
u/l
21.4
16.1
—
10
42
(3042936) Bacteria identified in Isolate by Culture
161
1187
1.43
3.92
2.1
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
14
43
3.29
3.91
1.3
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
52
294
1.81
3.86
1.3
1.6
—
155.4
—
0
13
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
254
2029
1.34
3.79
2.3
2.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
101
684
1.53
3.77
3.4
4.4
%
0.6
0.9
0.71
27
212
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
290
1.80
3.72
2.4
2.6
g/l
3.2
3.2
0.18
43
232
(40768800) Prostate Pathology biopsy report
38
197
1.97
3.67
1.2
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
18
67
2.72
3.67
1.4
1.2
g/l
6.3
7.0
0.45
13
44
(3024139) IgG subclass 3 [Mass/volume] in Serum
18
67
2.72
3.67
1.4
1.2
g/l
0.4
0.4
0.08
13
44
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
67
2.72
3.67
1.4
1.2
g/l
2.8
2.8
0.03
13
44
(3047189) Immunofixation for 24 hour Urine
14
45
3.14
3.66
1.1
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
27
123
2.23
3.63
1.0
1.1
iu/ml
4.0
30.0
—
6
27
(36660697) Celiac disease serology panel - Serum
89
591
1.56
3.63
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
125
2.19
3.50
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
91
613
1.53
3.49
3.5
4.3
%
0.3
0.5
0.65
21
154
(4062490)
18
69
2.64
3.48
1.4
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
225
1787
1.34
3.46
4.4
4.6
—
—
—
0
0
(3036489) Thrombin time
51
300
1.74
3.35
1.8
2.1
s
21.0
21.8
0.69
43
271
(3007461) Platelets [#/volume] in Blood
930
9005
1.78
3.29
32.2
21.5
e9/l
250.4
247.7
0.62
915
8775
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
222
1773
1.33
3.28
3.5
3.1
ug/l
0.8
0.7
0.20
158
1161
(3035941) MCH [Entitic mass]
930
9009
1.76
3.23
32.1
21.4
pg
30.3
30.4
1.42
922
8865
(3024731) MCV [Entitic volume]
930
9009
1.76
3.23
32.2
21.4
fl
90.7
91.2
3.33
922
8866
(3026361) Erythrocytes [#/volume] in Blood
930
9010
1.76
3.21
32.2
21.5
e12/l
4.6
4.5
6.47
910
8759
(3010813) Leukocytes [#/volume] in Blood
930
9011
1.76
3.20
32.3
21.5
e9/l
7.1
6.7
9.07
911
8757
(3013512) EKG study
292
2429
1.29
3.19
5.0
3.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
197
1553
1.34
3.17
2.0
1.7
nmol/l
1210.5
1197.3
0.06
150
1172
(3000963) Hemoglobin [Mass/volume] in Blood
930
9013
1.75
3.17
32.4
21.6
g/l
137.3
135.5
3.07
923
8869
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
41
230
1.82
3.16
2.2
2.8
g/l
3.7
3.7
0.10
41
219
(3017143) Hepatitis C virus Ab [Presence] in Serum
111
797
1.44
3.13
2.1
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
105
748
1.45
3.09
2.4
2.4
ug/l
12.5
7.0
0.54
88
667
(3048689) Calprotectin [Mass/mass] in Stool
123
903
1.41
3.07
2.5
2.2
ug/g
142.3
134.2
0.06
96
722
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
533
4781
1.25
3.06
2.8
2.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
177
1.89
2.94
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
177
1.89
2.94
1.4
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
46
2.85
2.92
1.8
3.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
19
82
2.34
2.92
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
57
360
1.62
2.91
2.2
2.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
115
2.11
2.90
1.9
1.8
g/l
1.3
0.9
0.34
19
85
(3042733) HLA Ab [Presence] in Serum
9
22
4.12
2.88
6.3
4.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
52
324
1.64
2.81
6.4
4.1
mmol/l
25.2
25.0
0.20
46
313
(3028026) IgM [Mass/volume] in Serum or Plasma
73
493
1.52
2.81
2.0
1.8
g/l
1.4
1.4
0.00
64
458
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
53
2.67
2.80
2.7
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
54
340
1.62
2.80
1.3
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
93
661
1.45
2.78
2.9
2.8
ml/min/173m2
56.6
66.6
1.84
56
262
(3036525) Urea [Moles/time] in 24 hour Urine
5
6
8.37
2.75
3.6
4.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
14
5.03
2.73
1.0
1.2
umol/24h
1.9
1.9
—
7
14
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
219
1.77
2.72
1.3
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
10
6.03
2.70
1.3
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
81
565
1.47
2.68
3.9
4.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
216
1767
1.29
2.64
1.9
1.7
pmol/l
113636795.2
30319943.9
0.45
176
1471
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
125
946
1.37
2.63
2.0
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
74
509
1.49
2.62
1.5
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
83
587
1.45
2.56
1.6
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
85
606
1.44
2.52
2.3
2.8
g/l
10.7
10.8
0.15
76
559
(3014765) Yersinia sp identified in Stool by Organism specific culture
40
241
1.69
2.48
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
40
241
1.69
2.48
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
33
188
1.78
2.48
3.2
3.1
nmol/l
0.8
0.8
0.01
27
152
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
21
3.83
2.46
1.8
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
234
1.69
2.45
2.6
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
103
2.06
2.43
1.2
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
37
220
1.71
2.41
1.6
2.1
mg/l
12.4
12.1
0.07
30
203
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
153
1.85
2.40
3.3
3.3
e9/l
4.0
4.2
0.27
28
153
(3035320) C reactive protein [Mass/volume] in Body fluid
14
58
2.43
2.37
2.8
2.2
—
—
—
0
0
(4010399)
84
605
1.43
2.37
1.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
13
52
2.52
2.36
1.5
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
52
2.52
2.36
1.8
1.5
u/l
1.7
9.2
—
7
25
(42529406) Shigella sp [Presence] in Stool by Culture
40
245
1.66
2.34
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
32
184
1.76
2.34
1.7
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
53
2.47
2.28
1.1
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
113
1.97
2.26
1.3
1.2
u/ml
1.3
2.3
—
7
35
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
18
3.91
2.25
1.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
9
5.58
2.21
10.0
6.3
mmol/l
5.6
6.6
—
5
9
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
165
1.78
2.21
1.6
2.1
u/l
2813.8
3533.8
—
5
58
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
158
1.80
2.19
3.5
3.6
%
57.0
57.8
0.10
28
158
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
20
101
2.00
2.16
1.3
2.3
pg
33.3
32.6
0.24
20
101
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
19
3.70
2.15
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
60
415
1.48
2.11
4.1
3.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
69
493
1.43
2.06
1.5
1.5
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
15
4.02
2.04
1.2
1.2
%
100.8
88.3
—
6
15
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
15
4.02
2.04
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
69
496
1.42
2.00
1.2
1.2
iu/ml
136.9
141.5
0.03
22
197
(3021788) Differential panel - Synovial fluid
26
148
1.78
2.00
1.4
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
233
1.61
1.98
1.6
1.6
iu/ml
0.0
0.1
—
9
46
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
21
112
1.89
1.97
1.3
1.2
u/ml
3.0
4.2
—
8
43
(4094501)
36
226
1.62
1.96
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
32
196
1.65
1.92
2.1
3.4
umol/l
30.0
33.3
0.45
26
167
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
49
333
1.50
1.90
3.8
3.5
u/ml
2502.4
4314.1
0.19
42
283
(1761482) Bacteria [#/volume] in Urine by Culture
34
215
1.60
1.81
5.0
4.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
73
2.07
1.81
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
35
2.59
1.80
1.2
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
11
47
2.36
1.78
2.3
1.3
ug/l
9.5
6.3
0.49
11
39
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
50
347
1.46
1.77
1.8
1.9
ug/l
1.3
2.3
0.49
43
312
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
31
193
1.63
1.76
1.5
1.8
iu/l
5.2
5.6
—
10
59
(3000570) Elastase.pancreatic [Mass/mass] in Stool
39
257
1.54
1.76
1.4
1.4
ug/g
286.8
280.8
0.05
22
152
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
41
2.45
1.76
1.0
1.1
—
—
—
0
0
(4268621)
15
74
2.04
1.75
2.5
2.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
18
3.35
1.75
1.8
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
165
1373
1.24
1.75
1.3
1.3
iu/ml
40.4
33.6
0.18
46
441
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
12
54
2.24
1.74
1.2
1.4
u/l
14.8
13.2
0.18
12
49
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
157
1305
1.24
1.68
1.3
1.3
u/ml
19.1
11.7
0.31
52
491
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
104
1.84
1.68
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
62
2.11
1.66
1.2
1.3
mmol/l
12.4
11.9
—
8
16
(3019897) Erythrocyte distribution width [Ratio] by Automated count
16
83
1.94
1.65
4.3
2.3
%
13.6
13.1
0.89
16
83
(4198724)
7
25
2.81
1.65
1.9
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
69
2.04
1.65
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
277
2441
1.19
1.64
4.7
4.3
%
23.3
20.9
1.73
143
1165
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
146
1210
1.24
1.61
1.3
1.5
—
—
—
0
0
(3019225) pH of Specimen
101
802
1.29
1.59
6.6
4.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
29
183
1.60
1.59
1.4
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
7
26
2.70
1.58
1.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
26
2.70
1.58
1.6
1.3
ug/l
45.1
62.0
—
7
26
(3024932) HLA-DR beta [Type]
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
323
2893
1.17
1.57
3.5
2.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
37
249
1.51
1.54
1.9
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
33
2.44
1.54
2.3
2.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
43
0.00
1.52
0.0
1.3
—
—
—
0
0
(3000492) Spirometry study
99
789
1.28
1.52
1.7
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
38
2.38
1.46
1.9
3.0
u/ml
449.4
1148.2
—
9
38
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
212
1.53
1.45
1.7
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
66
1.98
1.44
1.2
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
333
3008
1.16
1.44
5.6
5.0
ug/l
2.5
2.4
0.10
307
2698
(21494755) Public health laboratory ask at order entry panel
50
676
0.73
1.42
1.4
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
60
2.01
1.38
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
60
2.01
1.38
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
60
2.01
1.38
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
21
127
1.67
1.37
1.7
1.2
—
—
—
0
0
(1002224) Polysomnography panel
47
341
1.40
1.36
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
441
0.67
1.36
1.2
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
128
1.65
1.34
1.6
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
68
1.92
1.33
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
61
1.98
1.33
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
61
1.98
1.33
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
61
1.98
1.33
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
144
1.61
1.33
2.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
24
2.51
1.30
1.5
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
24
2.51
1.30
2.2
2.6
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
14
76
1.85
1.30
1.1
1.2
—
38.2
—
0
5
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
34
2.36
1.29
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
17
99
1.73
1.27
1.5
1.4
e6/l
871.5
1903.2
—
10
71
(3003694) ABO and Rh group [Type] in Blood
247
2199
1.17
1.27
1.5
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
77
1.83
1.26
1.5
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
296
1.40
1.24
2.0
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
21
131
1.62
1.24
2.3
1.4
u/ml
124.1
110.3
—
7
24
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
31
212
1.48
1.24
1.8
1.6
—
—
—
0
0
(4146454)
17
100
1.71
1.24
2.9
2.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
55
418
1.33
1.22
1.4
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
19
2.64
1.21
1.6
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
48
358
1.36
1.21
1.8
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
49
367
1.35
1.20
1.1
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
28
189
1.50
1.20
2.1
1.5
e6/l
11.2
26.8
0.42
21
145
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
189
1.50
1.20
2.2
1.6
e6/l
5100.2
164.8
0.64
22
148
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
50
654
0.75
1.17
1.6
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
30
2.34
1.12
2.0
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
8
40
2.01
1.12
1.3
1.3
mmol/l
6.0
6.4
—
8
40
(3044242) Glucose [Moles/volume] in Arterial blood
10
51
1.97
1.11
1.9
3.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
69
551
1.27
1.09
4.0
2.9
—
—
—
0
0
(3020891) Body temperature
45
340
1.34
1.06
7.5
4.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
121
1.58
1.06
1.2
1.7
—
—
—
0
0
(4034850)
17
265
0.64
1.06
22.0
10.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
104
874
1.21
1.05
1.6
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
50
385
1.31
1.05
1.2
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
29
204
1.43
1.04
1.4
1.8
e6/l
5723.9
16391.8
1.77
16
154
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
9
47
1.92
1.02
1.1
1.7
u/l
4.4
6.7
—
9
37
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
326
1.33
1.00
2.2
1.9
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
16
99
1.63
1.00
1.2
1.3
—
66.5
—
0
6
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
206
1.42
0.99
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
66
533
1.26
0.97
3.3
2.8
e9/l
4.4
4.1
0.39
50
412
(3044290) Cell count panel - Cerebral spinal fluid
24
166
1.46
0.95
2.3
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
93
1.62
0.94
1.2
1.9
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
28
2.15
0.91
1.2
1.3
%
106.0
109.5
—
6
22
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
219
0.63
0.91
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
33
245
1.36
0.90
2.1
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
29
211
1.39
0.89
1.2
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
79
1.65
0.88
3.3
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
56
1.79
0.88
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
43
1.87
0.87
4.6
2.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
136
1.48
0.87
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
187
1.40
0.86
1.2
1.4
—
—
—
0
0
(4306422)
16
104
1.55
0.85
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
80
1.63
0.85
1.5
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
45
1.78
0.84
1.5
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
45
1.78
0.84
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
112
972
1.17
0.83
1.8
1.8
%
1.5
1.5
0.17
96
840
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
113
1.51
0.82
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
105
907
1.18
0.82
3.5
4.3
ug/l
11.2
29.1
1.02
78
763
(21494434) Karyotype in Bone marrow
13
81
1.61
0.81
1.1
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
37
286
1.31
0.79
1.9
2.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
29
218
1.34
0.75
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
53
1.70
0.75
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
53
1.70
0.75
1.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
141
1.43
0.75
1.2
1.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
25
2.01
0.72
1.2
1.3
ug/l
7.9
9.4
—
5
25
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
28
211
1.34
0.72
1.0
1.1
u/ml
1.2
5.1
—
5
23
(40768806) Pleura Pathology biopsy report
14
92
1.53
0.72
1.5
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
76
1.59
0.72
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
93
1.51
0.69
2.5
3.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
85
1.54
0.69
2.2
3.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
161
1.37
0.68
1.3
1.2
—
7.4
—
0
12
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
110
1.46
0.68
1.4
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
59
1.53
0.68
2.1
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
86
1.52
0.66
4.8
2.7
—
—
—
0
0
(44806420)
5
28
1.79
0.66
2.6
2.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
23
171
1.35
0.66
1.3
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
177
0.67
0.63
1.8
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
91
1034
0.87
0.62
14.4
6.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
96
1.47
0.61
2.3
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
8
50
1.60
0.61
1.0
1.0
—
7.9
—
0
13
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
20
0.00
0.60
0.0
1.5
—
33.5
—
0
13
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
503
1.18
0.58
1.3
1.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
6
35
1.72
0.57
1.3
2.1
umol/l
74.5
50.8
—
6
26
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
54
1.49
0.57
1.3
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
81
1.49
0.57
2.0
2.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
73
1.51
0.56
2.0
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
73
1.51
0.56
1.0
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
28
221
1.27
0.56
1.3
1.2
—
2.5
—
0
7
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
116
1.39
0.54
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
63
1.43
0.52
1.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
100
1.41
0.52
1.1
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
191
1775
1.09
0.51
5.4
3.9
kg/l
1.0
1.0
0.23
44
244
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
145
1.32
0.49
1.2
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.3
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.3
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
208
1.26
0.48
1.5
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
74
655
1.14
0.48
2.2
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
7
47
1.49
0.47
1.4
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
94
1.39
0.46
1.8
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
118
1078
1.11
0.46
1.4
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
49
1.43
0.46
2.3
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
422
1.17
0.45
2.7
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
147
1.30
0.45
1.7
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
23
184
1.26
0.43
1.9
2.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
157
1.28
0.43
1.1
1.2
—
—
—
0
0
(4281824)
11
78
1.41
0.43
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
113
1.33
0.43
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
91
0.66
0.42
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
93
0.64
0.42
1.3
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
94
0.64
0.42
1.3
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
57
1.41
0.42
1.1
1.5
g/l
1.0
1.0
—
8
57
(4211845)
5
33
1.52
0.41
4.6
3.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
15
0.00
0.41
0.0
8.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
105
1.34
0.41
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
25
304
0.82
0.41
2.6
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
114
1.32
0.41
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
114
1.32
0.41
1.3
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
132
1.29
0.40
1.7
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
88
1.37
0.40
1.4
1.4
e6/l
202822.9
38147.2
—
7
52
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
251
1.20
0.39
2.0
2.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.1
—
2.1
—
0
8
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
115
1.31
0.39
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
115
1.31
0.39
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
169
1.25
0.39
2.1
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
67
1.35
0.38
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
94
1026
0.91
0.38
5.8
4.6
%
29.8
32.3
1.58
64
679
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.37
1.1
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
27
225
1.21
0.37
1.5
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
69
1.31
0.37
2.3
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
125
1.28
0.37
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
126
1.27
0.35
1.9
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
200
1.21
0.34
1.2
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
45
1.34
0.33
1.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
6
46
1.31
0.33
1.3
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
46
1.31
0.33
1.2
2.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
46
1.31
0.33
1.5
3.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
46
1.31
0.33
1.0
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
90
0.66
0.33
1.3
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
155
1.23
0.32
1.7
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
240
0.83
0.31
2.7
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
120
1.25
0.30
2.0
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
231
1.17
0.30
1.2
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
141
0.78
0.29
1.2
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
109
0.73
0.29
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
109
0.73
0.29
1.4
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
1.6
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
110
0.73
0.29
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
110
0.73
0.29
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
94
1.28
0.28
1.1
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
63
1.27
0.27
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
116
0.77
0.27
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
196
1.18
0.27
1.7
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
113
1.24
0.26
1.9
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
55
501
1.10
0.26
1.7
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
188
1.17
0.25
1.1
1.3
miu/ml
81.4
242.0
—
8
85
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
123
1.22
0.25
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
74
1.22
0.25
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
198
1.17
0.24
1.7
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
85
0.70
0.24
1.2
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
199
1.16
0.23
1.7
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
115
1.22
0.23
1.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
200
1.15
0.22
1.7
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
189
0.84
0.22
1.6
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
95
0.73
0.22
2.1
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
95
0.73
0.22
1.1
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
116
1.21
0.22
1.1
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
41
1.22
0.22
3.6
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
6.8
—
0
10
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
102
0.78
0.21
1.0
1.1
g/l
1.5
1.5
—
8
94
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
43
1.16
0.21
1.8
1.2
ug/l
3.3
2.4
—
5
33
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
64
596
1.08
0.20
2.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
48
1.25
0.20
1.2
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
6
49
1.23
0.20
2.7
1.8
—
98.0
—
0
6
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
6
50
1.20
0.19
1.3
1.9
e9/l
0.2
0.2
—
6
44
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
241
1.12
0.19
1.2
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
6
52
1.15
0.19
1.3
1.9
e6/l
382.7
643.7
—
6
44
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
109
1.20
0.18
1.2
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
80
0.75
0.15
1.7
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
93
1.18
0.14
2.4
4.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
189
1.11
0.14
1.7
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
96
0.83
0.13
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
188
0.90
0.11
3.2
3.8
mg/l
23.3
27.3
—
7
118
(40761535) Cells panel - Urine sediment
73
705
1.04
0.09
4.0
3.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
54
1.11
0.09
1.7
3.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
6
54
1.11
0.09
1.0
1.1
mg/l
26.3
41.0
—
6
46
(3023419) Bacteria identified in Sputum by Culture
10
113
0.88
0.08
1.5
2.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
71
0.84
0.07
1.2
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.07
1.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.07
1.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.07
1.1
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
97
994
0.97
0.07
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
83
0.84
0.07
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
196
1.07
0.07
1.2
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
86
1.05
0.07
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
89
1.12
0.07
2.2
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
90
0.89
0.06
1.1
1.1
—
—
—
0
0
(44790049)
8
94
0.85
0.06
1.1
1.6
—
—
—
0
0
(44790048)
8
94
0.85
0.06
1.1
1.6
—
—
—
0
0
(44806118)
8
94
0.85
0.06
1.1
1.6
—
—
—
0
0
(44790047)
8
94
0.85
0.06
1.1
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
10
111
0.90
0.06
4.7
2.6
mmol/l
3.9
4.0
—
10
111
(3035285) Chloride [Moles/volume] in Venous blood
10
111
0.90
0.06
4.7
2.6
mmol/l
104.4
105.5
—
10
111
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
119
1.09
0.06
2.7
2.8
—
859.1
—
0
9
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
110
0.91
0.05
4.7
2.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
601
0.98
0.02
1.3
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
122
1.07
0.02
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
123
1.06
0.01
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
39
383
1.02
0.01
1.4
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
124
1.05
0.00
1.2
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
19
184
1.03
0.00
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
144
0.97
0.00
1.2
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
118
1.02
0.00
1.6
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
27
273
0.99
0.00
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
145
1.04
0.00
1.3
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(44813793)
5
57
0.88
0.00
1.2
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
12.3
—
0
8
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
2.2
—
1.9
—
0
5
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.6
—
0
5
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
77
0.91
0.00
1.7
1.7
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
0.6
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
7.8
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
89
1.01
0.00
2.7
1.6
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(4024509)
7
71
0.99
0.00
1.9
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPERALDO and mortality.

Females

Parameter HR [95% CI] p-value
E4_HYPERALDO 1.424 [1.23, 1.65] < 0.001
Birth year 0.993 [0.98, 1.0] 0.123

During the follow-up period (1.1.1998 — 31.12.2019), 414 out of 2277 females with E4_HYPERALDO died.

Males

Parameter HR [95% CI] p-value
E4_HYPERALDO 1.218 [1.05, 1.41] 0.009
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 357 out of 2005 males with E4_HYPERALDO died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPERALDO.

N-year risk Females Males
1 0.081% 0.205%
5 0.68% 1.319%
10 2.096% 3.219%
15 3.905% 6.3%
20 7.079% 10.338%

Relationships between endpoints

↥

Index endpoint: E4_HYPERALDO – Hyperaldosteronism

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data